Nicox S.A. (OTCMKTS:NICXF) Sees Large Decline in Short Interest

Nicox S.A. (OTCMKTS:NICXFGet Free Report) saw a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 31,100 shares, a drop of 42.0% from the October 31st total of 53,600 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 311.0 days.

Nicox Stock Performance

OTCMKTS:NICXF remained flat at $0.24 on Thursday. Nicox has a 1-year low of $0.24 and a 1-year high of $0.24. The stock’s fifty day moving average price is $0.39 and its two-hundred day moving average price is $0.42.

About Nicox

(Get Free Report)

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.

Further Reading

Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.